|
Clinical trials are costly—how can R&D teams predict failures before they happen? In this MedTech Snapshot, Arif Padamsee explores the balance between preclinical testing, simulations, and real-world data to set new products up for success.
Transcript:
0 Comments
When you’re early in the development process it can seem like there’s a never ending list of activities and projects your R&D team needs to take on. When you’re in this mode its vital R&D leaders assess time, resources and associated risks with the product they’re developing. Medical device product development executive Arif Iftekhar walks us through how to focus your team and address the most important product risks head on at an early stage.  In this Medtech Snapshot episode we feature Nidus Biomedical COO Glen Rabito talking through the five considerations to keep product development moving forward, especially in the early phases of development. In this 2-part series of Medtech Snapshot we're joined by Square-1 Engineering Director of Delivery & Operations Trisha Aure as she walks us through the highlights of our article 'FDA Announcement: 21 CFR 820 and ISO 13485 Guidance' Hear the areas where 21 CFR 820 differs most from ISO 13485 and what this means for medical device OEMs. Part-2 of this series will cover the process to transition and key considerations when doing so. Transcript:AboutThe MedTech Snapshot Podcast, hosted by Square-1 Engineering’s Travis Smith, features quick insights from industry executives on topics like startups, funding, product development, finance, manufacturing, and more. Archives
June 2025
Categories
All
|
RSS Feed
White Papers & Articles
Check Out the 4-Minute Medical Device Podcast
|
|
